Thomas B. Neff
2017
In 2017, Thomas B. Neff earned a total compensation of $7.1M as Chief Executive Officer at FibroGen, a 35% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $693,000 |
|---|---|
| Option Awards | $2,850,751 |
| Salary | $840,000 |
| Stock Awards | $2,684,780 |
| Other | $20,160 |
| Total | $7,088,691 |
Neff received $2.9M in option awards, accounting for 40% of the total pay in 2017.
Neff also received $693K in non-equity incentive plan, $840K in salary, $2.7M in stock awards and $20.2K in other compensation.
Rankings
In 2017, Thomas B. Neff's compensation ranked 1,146th out of 14,666 executives tracked by ExecPay. In other words, Neff earned more than 92.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,146 out of 14,666 | 92nd |
Division Manufacturing | 384 out of 5,772 | 93rd |
Major group Chemicals And Allied Products | 102 out of 2,075 | 95th |
Industry group Drugs | 69 out of 1,731 | 96th |
Industry Pharmaceutical Preparations | 56 out of 1,333 | 96th |
Source: SEC filing on April 24, 2018.
Neff's colleagues
We found two more compensation records of executives who worked with Thomas B. Neff at FibroGen in 2017.